There has been a reported breakthrough in the race to develop a Covid-19 vaccine by scientists at Oxford University. An immune response to the new vaccine called ChAdOx1 nCoV-19 has indicated a strong “double defence”, whereby both antibodies and “killer” T-cells were reported to have been present in blood samples from volunteers in the first human phase of testing. The information was provided to The Telegraph by a senior source. Further media coverage will be reported on these developments on Monday 20th July.
- Finland’s revised clinical guidelines for dementia - 25th September 2023
- Extreme heat likely to wipe out humans and mammals - 25th September 2023
- Reflecting on menopause in the workplace - 25th September 2023